Burns, Chemical: Clinical Trials

5 trials for Burns, Chemical, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 available, 1 not yet recruiting. 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 22Completed 1, Not yet recruiting 1

Follow Burns, Chemical: new trials by email Literature Review of Burns, Chemical trials Research Report on Burns, Chemical

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial
Subconjunctival injection of 1 mL with 5 million allogeneic BM-MSCs; one repeat within 21 days. - Chemical Burns, Ocular Burns
Phase 2Not yet recruitingFondation Ophtalmologique Adolphe de Rothschild212026-03-012026-01-09
the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn
human bone marrow MSC - Chemical Burns
Phase 2CompletedSun Yat-sen University162015-07-012019-04-11
Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation
ARGOS-IO system - Graft vs Host Disease, Congenital Aniridia
Not applicableCompletedImplandata Ophthalmic Products GmbH132015-03-012025-02-27
Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
cultivated oral mucosal epithelial sheet transplantation - Limbal Stem Cell Deficiency, Stevens-johnson Syndrome
AvailableSeoul National University Hospital2014-05-012016-04-20
Glucose Control in Severely Burned Patients
Humulin R, Metformin - Burns
Not applicableCompletedSunnybrook Health Sciences Centre452011-03-012022-03-28

Narrower conditions

Stevens-Johnson Syndrome (2)  ·  Aniridia (1)  ·  Burns (1)  ·  Graft vs Host Disease (1)  ·  Hydrophthalmos (1)  ·  Limbal Stem Cell Deficiency (1)  ·  Pemphigoid, Benign Mucous Membrane (1)

Broader conditions

Wounds and Injuries (5)  ·  Burns (4)  ·  Chemically-Induced Disorders (2)  ·  Dermatitis (2)  ·  Drug Eruptions (2)  ·  Drug Hypersensitivity (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)  ·  Erythema (2)  ·  Erythema Multiforme (2)  ·  Eye Diseases (2)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Delayed (2)  ·  Immune System Diseases (2)  ·  Mouth Diseases (2)  ·  Skin Diseases (2)

Interventions

Insulin (1)  ·  Metformin (1)

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Implandata Ophthalmic Products GmbH (1)  ·  Seoul National University Hospital (1)  ·  Sun Yat-sen University (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

Canada (1)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Liang Dan, MD (1)  ·  Marc G Jeschke, MD PhD (1)  ·  Mee Kum Kim, MD, PhD (1)  ·  Thomas Neuhann, Prof. MD (1)

Results publications

PMID 4186059